For instance, a recent report suggests combining heparanase inhibitors with IGF-1R antagonists for treatment of metastatic SS [170], and a combined therapy including BET inhibitors has been set forth for EwS [171]. The gene discussed is IGF1R; the disease is synovial sarcoma.